Icon

ADZENYS ER (nda204325)- (EQ 1.25MG BASE/ML)

AMPHETAMINE NEOS THERAPS INC
EQ 1.25MG BASE/ML
No Yes
2032-Jun-28 Expired
None None
None No
ADZENYS ER is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 1.25MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.